Table: Peptidream - 9-MTH parent results
May 14 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Mar 31, 2019 Mar 31, 2018 Jun 30, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.93 1.14
(+157.3 pct) (-19.8 pct)
Operating 675 mln loss 1.33
Recurring 914 mln loss 1.19
Net 694 mln loss 831 mln
EPS 5.63 yen loss 6.93 yen
EPS Diluted 5.29 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner